or
forgot password

    • cancer clinical trials in clinton, MD

    • Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
    Oncology-Hematology Associates, P.A.
    Clinton, Maryland 20735
    Multiple Myeloma and Plasma Cell Neoplasm
    Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
    Oncology-Hematology Associates, P.A.
    Clinton, Maryland 20735
    Breast Cancer
    A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
    Oncology-Hematology Associates, P.A.
    Clinton, Maryland 20735
    Sickle Cell Disease
    Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    Oncology-Hematology Associates, P.A.
    Clinton, Maryland 20735
    Pancreatic Cancer
    Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    Oncology-Hematology Associates, P.A.
    Clinton, Maryland 20735
    Leukemia, Lymphoma
    Non-small Cell Lung Cancer Registry
    Oncology-Hematology Associates, PA
    Clinton, Maryland 20735
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Oncology Hematology Associates, PA
    Clinton, Maryland 20735
    Multiple Myeloma
    Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
    Oncology-Hematology Associates, P.A.
    Clinton, Maryland 20735
    Multiple Myeloma
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    Oncology - Hematology Associates, PA Oncology Hematology Assoc
    Clinton, Maryland 20735
    Multiple Myeloma